Jul 19, 2023 / 01:30PM GMT
Operator
Ladies and gentlemen, welcome to the Sobi KOL Investor Event, the journey for Vonjo Conference Call and live webcast. I am Alice, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.
Guido Oelkers - Swedish Orphan Biovitrum AB(publ)-CEO&President
Yes. Thank you so much, and welcome to this conference, which is dedicated to Vonjo. Before we start, I would like to provide you with some forward-looking statement as per usual, and let's go straight to the next slide. And today, it's really about Vonjo, pacritinib, our recent acquisition that we got going with CTI. And as we discussed yesterday in our earnings call, we wanted to provide you with some more information on Vonjo. And basically, today, I'm really blessed to be (inaudible) by
Swedish Orphan Biovitrum AB (publ) KOL Event Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot